Imtm Gmbh

Serumwerk Bernburg Ag

Keyneurotek Pharmaceuticals Ag

Michael Täger

Siegfried Ansorge

Dieter Koegst

Gerhard Fries

Frank Striggow

Klaus Neubert

Peter Röhnert

Ute Bank

Klaus G Reymann

Jürgen Faust

Petra Fuchs

Bianca Senns

Ulrich Schröder

Irene Reichstein

Compounds of the general formulae (1) and (2)A-B-D-B'-A&#x2032;&#x2003;&#x2003;(1)andA-B-D-E&#x2003;&#x2003;(2)in which 

Dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other diseases

The present invention concerns the use of Provided is a drug composition and a method for using the composition for the prevention and the therapy of neurodegenerative diseases. The combination comprises at least two of the following substances: &#x3b1;-lipoic acid; ambroxol and one or several inhibitor(s) of the angiotension-converting enzyme (ACE).

Drug preparation comprising &#x3b1;-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases

The invention relates to the use of the combination of n-lipoic acid and effectors of the glutathione metabolism for the treatment of disturbances of the cellular thiol status and accompanying disorders in kidney replacement therapy.

Use of a medicament containing an effector of the glutathione metabolism together with &#x3b1;-lipoic acid in kidney replacement therapy

Growing community of inventors

Heinrichsberg, Germany

Michael Täger